Official Savings Programs from Novo Nordisk
Novo Nordisk, Wegovy's manufacturer, offers the Wegovy Savings Card for eligible patients. It reduces out-of-pocket costs to as low as $0 for a 28-day supply (up to 13 fills per year), but only applies to commercially insured patients—not government programs like Medicare or Medicaid. Enrollment is online via the official Wegovy site; income isn't a factor, though coverage varies by insurance.[1]
How to Get Wegovy at a Lower Price Without Insurance
Uninsured patients can use Novo Nordisk's Patient Assistance Program (PAP), which provides Wegovy free if household income is below 400% of the federal poverty level (e.g., $60,240 for a single person in 2024). Apply through NovoCare or call 1-888-809-3942; approval takes weeks and requires proof of income and no insurance.[1][2]
Pharmacy Discount Cards and Coupons
GoodRx and SingleCare offer coupons slashing Wegovy prices by 10-20% at pharmacies like Walmart or CVS—down to around $1,300-$1,400 per month from the $1,600+ list price. These stack with insurance in some cases but aren't valid with manufacturer cards. Search "Wegovy GoodRx" for instant printable coupons; no sign-up needed.[3][4]
Compounding Pharmacy Alternatives During Shortages
With ongoing FDA-noted shortages, some pharmacies compound semaglutide (Wegovy's active ingredient) for $200-$500/month—far cheaper than branded Wegovy. These aren't FDA-approved equivalents, so quality varies; check state boards for licensed compounders. Shortage status updates are on the FDA site, potentially ending soon.[5]
When Do Lower-Cost Options Like Generics Arrive?
No generics yet—Wegovy's key patents expire around 2032, per DrugPatentWatch.com, delaying competition.[6] Biosimilars might follow, but litigation could extend exclusivity. Track updates on DrugPatentWatch.com for challenges.
What If You're on Medicare or Have High Costs?
Medicare Part D covers Wegovy for weight loss in some cases post-2024 changes, with caps at $2,000/year out-of-pocket starting 2025. Check plans via Medicare.gov. Employer insurance often covers it better for obesity; appeal denials with doctor letters.7
[1]: NovoCare.com/wegovy/savings-offer.html
[2]: NovoCare.com/patient-assistance.html
[3]: GoodRx.com/wegovy
[4]: SingleCare.com/prescription/wegovy
[5]: FDA.gov/drugs/drug-shortages
[6]: DrugPatentWatch.com/patent/RE49548 (main semaglutide patent)